1. Pink Sheet
  3. >>Marketing & Advertising

Indivior Must Disband Suboxone Sales Force, Implement Executive Pay Recoupment Program

 
• By Brenda Sandburg

$600m settlement with DOJ over Suboxone marketing includes corporate integrity agreement and exclusion of subsidiary from government health programs. Indivior also agrees to pay $10m to FTC and be enjoined from future antitrust violations.

WASHINGTON, DC - MARCH 2018: Headquarters of the U.S. Justice Department. Art Deco aluminum torcheres at doorway. Renamed the Robert F. Kennedy Department of Justice Building in 2001.
DOJ inks second settlement over Suboxone marketing • Source: Shutterstock

A year after Indivior plc's former parent Reckitt Benckiser Group PLC reached a $1.4bn settlement with the US Department of Justice, Indivior has agreed to pay $600m more to resolve additional criminal and civil liability over the marketing of its opioid addiction treatment drug Suboxone Film (buprenorphine/naloxone).

This time the company agreed to disband its Suboxone sales force and entered into a corporate integrity agreement (CIA) requiring it to implement

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Marketing & Advertising

More from Compliance